Loading clinical trials...
Loading clinical trials...
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease: Insights From a Real-World Cohort
This study aim to investigate the association between plasma NT-proBNP levels and the presence, extent and severity of stenosis in patients with suspected coronary artery disease.
The investigators prospectively measured plasma NT-proBNP levels in consecutive patients referred to the center for elective diagnostic coronary angiography due to symptoms or signs of coronary artery disease over a two- year period. Patients with conditions known to elevate NT-proBNP levels, including heart failure, severe valvular disease, atrial fibrillation, severe chronic kidney disease (eGFR \< 30 mL/min), prior coronary artery bypass grafting, or age over 80 years, were excluded.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
IRCCS San Raffaele Hospital
Milan, Italy, Italy
IRCCS San Raffaele Hospital
Milan, Italy, Italy
Start Date
September 1, 2021
Primary Completion Date
June 29, 2025
Completion Date
July 31, 2025
Last Updated
June 10, 2025
800
ESTIMATED participants
BNP
DIAGNOSTIC_TEST
Lead Sponsor
IRCCS Ospedale San Raffaele
NCT06916520
NCT07444957
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions